Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Successful treatment of adult Dravet syndrome patients with cenobamate
Konstantin L. Makridis, Anna‐Lena Friedo, Christoph Kellinghaus, et al.
Epilepsia (2022) Vol. 63, Iss. 12
Open Access | Times Cited: 19

Showing 19 citing articles:

Adjunctive cenobamate in highly active and ultra‐refractory focal epilepsy: A “real‐world” retrospective study
Javier Peña‐Ceballos, Patrick B. Moloney, Tudor Munteanu, et al.
Epilepsia (2023) Vol. 64, Iss. 5, pp. 1225-1235
Open Access | Times Cited: 53
Real‐world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program
Vicente Villanueva, Daniel Santos‐Carrasco, Pablo Cabezudo‐García, et al.
Epilepsia Open (2023) Vol. 8, Iss. 3, pp. 918-929
Open Access | Times Cited: 51
New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: I. Role of GABA as a Modulator of Seizure Activity and Recently Approved Medications Acting on the GABA System
Emilio Perucca, Meir Bialer, H. Steve White
CNS Drugs (2023) Vol. 37, Iss. 9, pp. 755-779
Open Access | Times Cited: 42
Cenobamate as add‐on treatment for SCN8A developmental and epileptic encephalopathy
Cathrine E. Gjerulfsen, Madeleine J. Oudin, Francesca Furia, et al.
Epilepsia (2025)
Closed Access | Times Cited: 1
Real‐world use of cenobamate in adults: Efficacy and predictors of treatment response
Itai Loushy, Lilach Goldstein, Kathryn N. Devlin, et al.
Epilepsia (2025)
Closed Access | Times Cited: 1
Real-world experience with cenobamate: A systematic review and meta-analysis
Konstantin L. Makridis, Angela M. Kaindl
Seizure (2023) Vol. 112, pp. 1-10
Closed Access | Times Cited: 21
Cenobamate in refractory epilepsy: Overview of treatment options and practical considerations
Bettina Schmitz, Simona Lattanzi, Kristl Vonck, et al.
Epilepsia Open (2023) Vol. 8, Iss. 4, pp. 1241-1255
Open Access | Times Cited: 15
Cenobamate (YKP3089) and Drug-Resistant Epilepsy: A Review of the Literature
Jamir Pitton Rissardo, Ana Letícia Fornari Caprara
Medicina (2023) Vol. 59, Iss. 8, pp. 1389-1389
Open Access | Times Cited: 14
Cenobamate significantly improves seizure control in intellectually disabled patients with drug-resistant epilepsy and allows drug load reduction
Anna‐Lena Friedo, Benedikt Greshake, Konstantin L. Makridis, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 11
Treatment of Seizures in People with Intellectual Disability
Lance Watkins, Michael Kinney, Rohit Shankar
CNS Drugs (2025)
Closed Access
Research Progress on Precise Diagnosis and Treatment of Developmental and Epileptic Encephalopathies
涵 杨
Advances in Clinical Medicine (2025) Vol. 15, Iss. 01, pp. 6-12
Closed Access
A multicenter cohort study on the efficacy, retention, and tolerability of cenobamate in patients with developmental and epileptic encephalopathies
Elisa Buhleier, Susanne Schubert‐Bast, Susanne Knake, et al.
Epilepsia (2025)
Open Access
Successful treatment of pediatric patient with Dravet syndrome with cenobamate: Case report
Oleg V. Lobanov, Mary Bertrand
SAGE Open Medical Case Reports (2025) Vol. 13
Open Access
Cenobamate in Developmental and Epileptic Encephalopathies and Generalized Epilepsies: A Case Report on Epilepsy with Myoclonic-Atonic Seizures and Systematic Review of Current Evidence
Zafeirenia Vlakou, Anna Keramida, Vasiliki Kotsali-Peteinelli, et al.
Seizure (2025)
Open Access
Cenobamate efficacy in specific populations
Pavel Klein
Epilepsia (2025) Vol. 66, Iss. S1, pp. 29-37
Closed Access
Lack of effectiveness and seizure worsening with cenobamate in pediatric patients with Dravet syndrome
Rita Cagigal, Celia Romero‐del‐Rincon, Ana Laura Fernández‐Perrone, et al.
Epilepsia (2025)
Closed Access
Treatment with Cenobamate in Adult Patients with Lennox–Gastaut Syndrome: A Case Series
Giovanni Falcicchio, Simona Lattanzi, Francesco Negri, et al.
Journal of Clinical Medicine (2022) Vol. 12, Iss. 1, pp. 129-129
Open Access | Times Cited: 18
Treatment of status epilepticus: Physiology, pharmacology, and future directions
Raman Sankar
Epilepsia Open (2023) Vol. 8, Iss. S1
Open Access | Times Cited: 8
How Has the Treatment of Polish Children with Dravet Syndrome Changed? Future Perspectives
A Zielińska, Urszula Skarżyńska, Paulina Górka-Skoczylas, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1249-1249
Open Access
Gaining Awareness of Increasingly Persistent SCN1A Mutations
Jennifer C. Wong
Epiliepsy currents/Epilepsy currents (2023) Vol. 23, Iss. 3, pp. 179-181
Open Access
Page 1

Scroll to top